Drug resistance

WHO Global Strategy Recommendations

Fundamental priority recommendations are underlined and highlighted in bold
Other first priority recommendations are highlighted in bold.


International Aspects of Containing Antimicrobial Resistance

8.1 Encourage collaboration between governments, non-governmental organizations, professional societies and international agencies to recognize the importance of antimicrobial resistance, to present consistent, simple and accurate messages regarding the importance of antimicrobial use, antimicrobial resistance and its containment, and to implement strategies to contain resistance.

8.2 Consider the information derived from the surveillance of antimicrobial use and antimicrobial resistance, including the containment thereof, as global public goods for health to which all governments should contribute.

8.3 Encourage governments, non-governmental organizations, professional societies and international agencies to support the establishment of networks, with trained staff and adequate infrastructures, which can undertake epidemiologically valid surveillance of antimicrobial resistance and antimicrobial use to provide information for the optimal containment of resistance.

8.4 Support drug donations in line with the UN interagency guidelines.

8.5 Encourage the establishment of international inspection teams qualified to conduct valid assessments of pharmaceutical manufacturing plants.

8.6 Support an international approach to the control of counterfeit antimicrobials in line with the WHO guidelines.

8.7 Encourage innovative approaches to incentives for the development of new pharmaceutical products and vaccines for neglected diseases.

8.8 Establish an international database of potential research funding agencies with an interest in antimicrobial resistance.

8.9 Establish new, and reinforce existing, programmes for researchers to improve the design, preparation and conduct of research to contain antimicrobial resistance.

Share